NCT05585528View on ClinicalTrials.gov

Informing the Patient on the Type of Management, Surgical or Functional, After Rupture of the Anterior Cruciate Ligament

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Ligament Rupture
Interventions
PROCEDURE

Functional or surgical management in 1st intention

Proportion of patients after rupture of the anterior cruciate ligament of the knee, who will have functional or surgical management in 1st intention

Trial Locations (1)

69009

RECRUITING

Clinique de la Sauvegarde, Lyon

Sponsors

Collaborators (1)

Euraxi Pharma
All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT05585528 - Informing the Patient on the Type of Management, Surgical or Functional, After Rupture of the Anterior Cruciate Ligament | Biotech Hunter | Biotech Hunter